On Monday, the German Federal Health Ministry announced it suspend the use of AstraZeneca's COVID-19 vaccine over reports of dangerous blood clots in some recipients. The Ministry added that the decision was based on the Paul Ehrlich Institute's findings and added that the European Medicines Agency (EMA) would have the final say in whether the jab will be app
On Monday, the German Federal Health Ministry announced it suspend the use of AstraZeneca's COVID-19 vaccine over reports of dangerous blood clots in some recipients. The Ministry added that the decision was based on the Paul Ehrlich Institute's findings and added that the European Medicines Agency (EMA) would have the final say in whether the jab will be app
Contact your sales representative for commercial and promotional uses.